Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
alpha-2-macroglobulin like 1 | 0.590 | 0.692 | 1.6E-34 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1993 | 1993 | ||||||||
|
arylacetamide deacetylase | 0.631 | 0.615 | 2.9E-03 |
|
group | 0.060 | None | 1.000 | 6 | 0 | 2005 | 2019 | ||||||||
|
4-aminobutyrate aminotransferase | 0.628 | 0.538 | 6.3E-03 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2019 | 2019 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
group | 0.100 | None | 1.000 | 12 | 1 | 1993 | 2013 | ||||||||
|
ATP binding cassette subfamily B member 7 | 0.678 | 0.385 | 1.00 |
|
group | 0.020 | None | 1.000 | 2 | 1 | 2015 | 2016 | ||||||||
|
ATP binding cassette subfamily G member 2 (Junior blood group) | 0.419 | 0.885 | 2.1E-32 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
group | 0.100 | None | 1.000 | 12 | 0 | 1996 | 2012 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2000 | 2000 | |||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
acetylcholinesterase (Cartwright blood group) | 0.445 | 0.885 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
acyl-CoA synthetase long chain family member 5 | 0.641 | 0.500 | 2.9E-09 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
acyl-CoA synthetase long chain family member 6 | 0.686 | 0.500 | 3.2E-03 |
|
group | 0.310 | limited | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 1999 | 2015 | ||||||||
|
activin A receptor type 2A | 0.636 | 0.615 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
adenosine deaminase | 0.440 | 0.885 | 2.9E-12 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2011 | 2019 | ||||||||
|
ArfGAP with FG repeats 2 | 0.700 | 0.423 | 2.5E-04 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2006 | 2012 | ||||||||
|
activator of HSP90 ATPase activity 1 | 0.396 | 0.923 | 1.00 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2005 | 2017 | ||||||||
|
alpha 2-HS glycoprotein | 0.506 | 0.846 | 3.2E-10 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
aminoacyl tRNA synthetase complex interacting multifunctional protein 2 | 0.393 | 0.923 | 8.0E-03 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2005 | 2017 | ||||||||
|
A-kinase anchoring protein 12 | 0.566 | 0.615 | 3.6E-02 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2004 | 2019 | ||||||||
|
A-kinase anchoring protein 13 | 0.626 | 0.615 | 0.93 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1997 | 2018 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
group | 0.030 | None | 1.000 | 2 | 0 | 2003 | 2020 | ||||||||
|
5'-aminolevulinate synthase 2 | 0.606 | 0.577 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
ALK receptor tyrosine kinase | 0.396 | 0.846 | 3.2E-06 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
Leukemia, acute lymphocytic, susceptibility to, 1 | 0.636 | 0.269 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 |